Cargando…
High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases
PURPOSE: The aim of this study was to present a case of complete clinical response of renal clear cell carcinoma cutaneous metastases after high-dose-rate surface brachytherapy (HDR sBT). MATERIAL AND METHODS: An 81-year-old female diagnosed with stage IV clear cell renal carcinoma reported to our c...
Autores principales: | Raszewski, Łukasz, Chyrek, Artur J., Marciniak, Magdalena, Burchardt, Wojciech M., Biele¸da, Grzegorz M., Chicheł, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170516/ https://www.ncbi.nlm.nih.gov/pubmed/34122574 http://dx.doi.org/10.5114/jcb.2021.105947 |
Ejemplares similares
-
High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series
por: Chyrek, Artur J., et al.
Publicado: (2020) -
Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection
por: Chyrek, Artur Jan, et al.
Publicado: (2019) -
Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
por: Burchardt, Wojciech, et al.
Publicado: (2019) -
The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023) -
Thermal Boost Combined with Interstitial Brachytherapy in Early Breast Cancer Conserving Therapy—Initial Group Long-Term Clinical Results and Late Toxicity
por: Chicheł, Adam, et al.
Publicado: (2022)